This inventor holds 2 USPTO granted patents. Top assignee: Immunomolecular Therapeutics, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: The Innovative Contributions of Ryan Schutte
Introduction
Ryan Schutte is a notable inventor based in Gainesville, FL (US). He has made significant contributions to the field of autoimmune disorder treatments. With a total of 2 patents, Schutte's work focuses on advancing medical therapies that target specific immune responses.
Latest Patents
Schutte's latest patents include groundbreaking compounds and methods for treating autoimmune disorders by targeting HLA-DQ2. These compounds and compositions are useful in methods of treating, ameliorating, or inhibiting the development of autoimmune diseases by modulating the T cell response to antigenic peptides or fragments of antigenic peptides presented by the major histocompatibility (MHC) class II molecule, DQ2. His innovative approach aims to provide new avenues for patients suffering from these conditions.
Career Highlights
Ryan Schutte is currently associated with Immunomolecular Therapeutics, Inc., where he continues to develop his research and inventions. His work is characterized by a commitment to improving therapeutic options for patients with autoimmune disorders.
Collaborations
Some of his notable coworkers include Robert B Perni and James M Siedlecki. Their collaborative efforts contribute to the advancement of research in the field of immunology.
Conclusion
Ryan Schutte's innovative work in the treatment of autoimmune disorders showcases his dedication to medical advancements. His patents reflect a promising future for therapies targeting immune responses.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile